AakhusAE, WarshawEM. Allergy to methyldibromoglutaronitrile/phenoxyethanol (Euxyl K 400): regulatory issues, epidemiology, clinical characteristics, and management. Dermatitis, 2011; 22: 127–.
2.
TostiA, VincenziC, TrevisiP, et al.Euxyl K 400: incidence of sensitization, patch test concentration and vehicle. Contact Dermatitis, 1995; 33: 193–195.
3.
De GrootAC, van GinkelCJ, WeijlandJW. Methyldibromoglutaronitrile (Euxyl K 400): an important “new” allergen in cosmetics. J Am Acad Dermatol, 1996; 35: 743–747.
4.
SchnuchA, KeltererD, BauerA, et al.Quantitative patch and repeated open application testing in methyldibromo glutaronitrile-sensitive patients. Contact Dermatitis, 2005; 52: 197–206.
5.
WarshawEM, NelsenDD, SassevilleD, et al.Positivity ratio and reaction index: patch-test quality-control metrics applied to the North American Contact Dermatitis Group Database. Dermatitis, 2010; 21: 91–97.
